Race
Visit number vs Average duration of all respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during total estimated sleep duration from type III home sleep apnea test
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 316 | 23.3 | ± 4.8 | 22.9 | 13.2 | 43.1 | 2 | 318 |
Follow-up | 275 | 24.6 | ± 6.9 | 23.0 | 12.9 | 56.2 | 26 | 301 |
Treatment Arm vs Average duration of all respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during total estimated sleep duration from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 23.3 | ± 4.8 | 22.9 | 13.2 | 43.1 | 2 | 318 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 106 | 22.8 | ± 4.8 | 22.7 | 13.6 | 43.1 | - | 106 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 105 | 23.1 | ± 4.7 | 22.7 | 13.2 | 35.6 | 1 | 106 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 105 | 23.9 | ± 5.0 | 23.6 | 14.5 | 41.8 | 1 | 106 |
Treatment Arm vs Average duration of all respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during total estimated sleep duration from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 24.6 | ± 6.9 | 23.0 | 12.9 | 56.2 | 26 | 301 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 94 | 23.7 | ± 5.1 | 22.8 | 14.9 | 42.2 | 6 | 100 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 95 | 27.6 | ± 7.4 | 27.0 | 14.9 | 52.1 | 6 | 101 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 86 | 22.2 | ± 6.9 | 21.0 | 12.9 | 56.2 | 14 | 100 |
Age category vs Average duration of all respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during total estimated sleep duration from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 23.3 | ± 4.8 | 22.9 | 13.2 | 43.1 | 2 | 318 |
45-54 years | 52 | 21.5 | ± 4.2 | 21.7 | 13.2 | 36.1 | 1 | 53 |
55-64 years | 139 | 22.8 | ± 4.3 | 22.6 | 13.6 | 39.9 | - | 139 |
65 years or older | 125 | 24.5 | ± 5.3 | 23.7 | 15.0 | 43.1 | 1 | 126 |
Age category vs Average duration of all respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during total estimated sleep duration from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 24.6 | ± 6.9 | 23.0 | 12.9 | 56.2 | 25 | 300 |
45-54 years | 42 | 23.0 | ± 5.8 | 21.6 | 12.9 | 38.7 | 7 | 49 |
55-64 years | 117 | 24.0 | ± 7.0 | 22.4 | 13.5 | 56.2 | 10 | 127 |
65 years or older | 116 | 25.7 | ± 7.1 | 24.0 | 14.9 | 52.1 | 8 | 124 |
Gender of the participant vs Average duration of all respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during total estimated sleep duration from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 23.3 | ± 4.8 | 22.9 | 13.2 | 43.1 | 2 | 318 |
Female | 84 | 21.7 | ± 4.4 | 21.4 | 13.2 | 39.9 | - | 84 |
Male | 232 | 23.9 | ± 4.8 | 23.6 | 13.6 | 43.1 | 2 | 234 |
Gender of the participant vs Average duration of all respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during total estimated sleep duration from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 24.6 | ± 6.9 | 23.0 | 12.9 | 56.2 | 26 | 301 |
Female | 73 | 23.2 | ± 6.8 | 22.2 | 13.7 | 52.1 | 6 | 79 |
Male | 202 | 25.1 | ± 6.9 | 23.5 | 12.9 | 56.2 | 20 | 222 |
Race of the participant vs Average duration of all respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during total estimated sleep duration from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 315 | 23.3 | ± 4.8 | 22.9 | 13.2 | 43.1 | 2 | 317 |
White | 255 | 24.0 | ± 4.8 | 23.6 | 13.6 | 43.1 | 1 | 256 |
American Indian or Alaskan Native | 2 | 17.1 | ± 0.7 | 17.1 | 16.6 | 17.6 | - | 2 |
Black or African American | 42 | 20.5 | ± 3.5 | 20.0 | 13.2 | 28.6 | 1 | 43 |
Asian | 6 | 21.4 | ± 4.1 | 21.7 | 15.1 | 27.9 | - | 6 |
Native Hawaiian or other Pacific islander | 1 | 25.2 | - | 25.2 | 25.2 | 25.2 | - | 1 |
Other | 4 | 18.1 | ± 4.1 | 17.4 | 13.9 | 23.6 | - | 4 |
Multiple | 5 | 19.3 | ± 4.0 | 17.9 | 15.0 | 24.9 | - | 5 |
Race of the participant vs Average duration of all respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during total estimated sleep duration from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 274 | 24.6 | ± 6.9 | 23.0 | 12.9 | 56.2 | 25 | 299 |
White | 222 | 25.0 | ± 7.0 | 23.5 | 12.9 | 56.2 | 19 | 241 |
American Indian or Alaskan Native | 2 | 17.2 | ± 5.2 | 17.2 | 13.5 | 20.8 | - | 2 |
Black or African American | 35 | 23.6 | ± 7.2 | 21.7 | 14.9 | 52.1 | 6 | 41 |
Asian | 6 | 20.5 | ± 3.1 | 19.9 | 16.6 | 24.9 | - | 6 |
Native Hawaiian or other Pacific islander | 1 | 28.5 | - | 28.5 | 28.5 | 28.5 | - | 1 |
Other | 3 | 21.7 | ± 5.1 | 20.5 | 17.3 | 27.2 | - | 3 |
Multiple | 5 | 22.7 | ± 4.8 | 21.1 | 17.6 | 30.5 | - | 5 |